NDC 17856-0672-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0672
- Requested NDC
- 17856-0672-01
- Package NDCs from labels
- 17856-0672-1, 17856-0672-2, 17856-0672-3, 17856-0672-4, 17856-0672-01
- Manufacturer
- Atlantic Biologics Corp.
- Effective date
- 2025-10-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Atlantic Biologics Corp. | Atlantic Biologics Corp. | 2025-10-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0672-1 | Ondansetron | 60 in 1 CASE | SOLUTION | 60 | 1 | |
| 17856-0672-1 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-2 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-2 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-3 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-3 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-4 | Ondansetron | 72 in 1 CASE | SOLUTION | 72 | 1 | |
| 17856-0672-4 | Ondansetron | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0672-1 | ML - Milliliter | 17856-0672 | f5b97fd9-6050-46e6-b0da-693821d3938a | 1 | 2026-03-17 |
| 17856-0672-2 | ML - Milliliter | 17856-0672 | 787cc894-2cc2-4952-981c-f67609a087e3 | 1 | 2026-03-17 |
| 17856-0672-3 | ML - Milliliter | 17856-0672 | 53831650-5a50-4e31-9590-1c0ac60dc7ec | 1 | 2026-03-17 |
| 17856-0672-4 | ML - Milliliter | 17856-0672 | 68c3eadb-fcbb-40cc-80d0-0ddc4021b83a | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Select Consumer Group | 3ca80d74-1e8b-49d9-e063-6394a90a4312 | 2026-05-24 | Warnings | XF417D3PSL |
| Ondansetron | ONDANSETRON | Hospira, Inc. | d62cd60b-f87e-4825-bead-1d18bbc4e480 | 2026-05-23 | Warnings, Adverse reactions | NMH84OZK2B |
| Walgreens Adult Glycerin Laxative | GLYCERIN SUPPOSITORY | Walgreens | 5285403b-ab44-21a1-e063-6394a90a9fd0 | 2026-05-23 | Warnings | PDC6A3C0OX |
| Ondansetron | ONDANSETRON | Hospira, Inc. | 6a11f61b-2318-4382-2b91-4366e4bb53fa | 2026-05-22 | Warnings, Adverse reactions | NMH84OZK2B |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 8e255bc7-a120-460a-a32d-43931f8115de | 2026-05-21 | Warnings, Adverse reactions | B22547B95K |
| HEMORRHOIDAL WITH LIDOCAINE | GLYCERIN, LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE, WHITE PETROLATUM | CVS PHARMACY, INC | 4d870c68-9e72-464e-b0b8-900d0d661e43 | 2026-05-14 | Warnings | PDC6A3C0OX |
| Market Basket Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Demoulas Super Markets, Inc. | e15439c7-0e3c-7752-e053-2995a90a1a40 | 2026-05-11 | Warnings | XF417D3PSL |
| Meijer Effervescent Antacid and Pain Relief | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | Meijer Distribution Inc | 7305972b-aa0f-4daa-e053-2991aa0adfd7 | 2026-05-11 | Warnings | XF417D3PSL |
| ONDANSETRON | ONDANSETRON | A-S Medication Solutions | b60074e5-8e77-4dc0-9244-4205e4adbaef | 2026-05-11 | Warnings, Adverse reactions | NMH84OZK2B |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, POTASSIUM SORBATE, RESORCINUM, SALICYLICUM ACIDUM, | Energique, Inc. | 2831d28e-9cf1-4a72-9c6c-bb014d059558 | 2026-05-06 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN SUPPOSITORIES | Neilmed Pharmaceuticals Inc. | 374a2ca3-ee04-09a7-e063-6394a90ab760 | 2026-05-05 | Warnings | PDC6A3C0OX |
| REFRESH TEARS PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 9e1cba7b-84ed-47f3-b19a-121992834350 | 2026-04-24 | Warnings | PDC6A3C0OX |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Sportpharm LLC | c0be25a0-e13d-4242-93dc-0b86e82aadd7 | 2026-04-24 | Warnings, Adverse reactions | NMH84OZK2B |
| Pure Eyes Sterile Eyes | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | SAMSON PHARMACEUTICAL | c0234e82-211f-4731-ac48-12db13b16e8a | 2026-04-21 | Warnings | PDC6A3C0OX |
| Ondansetron | ONDANSETRON | Civica, Inc. | 70437694-0341-4f3b-824c-06843403443f | 2026-04-19 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Hikma Pharmaceuticals USA Inc. | 97713356-f42b-4a67-95f6-561afa68c0c2 | 2026-04-16 | Warnings, Adverse reactions | NMH84OZK2B |
| CLENPIQ | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | Ferring Pharmaceuticals Inc. | e95fff66-4ec0-4001-a727-33e66a5ec7d5 | 2026-04-15 | Warnings, Adverse reactions | XF417D3PSL |
| Ondansetron | ONDANSETRON | Sportpharm LLC | 98c1413c-ff7f-4554-9e9f-289038b39ca6 | 2026-04-14 | Warnings, Adverse reactions | NMH84OZK2B |
| Anticoagulant Sodium Citrate | TRISODIUM CITRATE DIHYDRATE | LABORATORIOS GRIFOLS SA | db8334be-5b8b-4811-811a-efbe32b6d147 | 2026-04-14 | Warnings | B22547B95K |
| Artificial Tears Lubricant Eye Drops | GLYCERIN, PROPYLENE GLYCOL | CVS Pharmacy | 28297fee-8185-4869-8f39-5bfbf8bf8bfd | 2026-04-13 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.